VAERS reports by lot

Novartis Vaccines Meningococcal lot A2X3Y: VAERS reports

30 VAERS reports list lot A2X3Y as a Novartis Vaccines Meningococcal vaccine, received between 2022-07-15 and 2023-10-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)919%
Neurological817%
Injection-site / Local reaction817%
Gastrointestinal715%
Dermatological (non-injection-site)612%
Allergic / Anaphylactic48%
Musculoskeletal48%
Cardiac / Cardiovascular12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan5
Massachusetts3
New York2
Virginia2
California2
Minnesota2
Iowa2
Tennessee1
Pennsylvania1
Florida1
South Dakota1
Texas1

Reports by month received

2022-072
2022-085
2022-095
2022-102
2022-111
2022-121
2023-012
2023-039
2023-041
2023-091
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.